Mouse thymus-leukemia antigens (TL) are aberrantly expressed on T lymphomas in C57BL/6 (B6) and C3H/He (C3H) mice, while they are not expressed on normal T lymphocytes in these strains. When N-butyl-N-nitrosourea (NBU), a chemical carcinogen, was administered orally to B6 and C3H strains, lymphoma development was slower than in T3 b -TL gene-transduced counterpart strains expressing TL ubiquitously as self-antigens, suggesting that anti-TL immunity may play a protective role. In addition, the development of lymphomas was slightly slower in C3H than in B6, which seems to be in accordance with the results of skin graft experiments indicating that both cellular and humoral immunities against TL were stronger in C3H than B6 mice. The interesting finding that B lymphomas derived from a T3 xpression of mouse thymus leukemia antigens (TL) belonging to the major histocompatibility complex (MHC) class Ib family is restricted to the intestines in all mouse strains, as well as to the thymus of TL + strains (e.g., A-strain and BALB/ c). [1][2][3][4] Recent studies by us and others showed that TL molecules bind with CD8αα + intestinal intraepithelial lymphocytes, CD8+ thymocytes and CD8αα + peripheral T lymphocytes.
5-8)In addition, their possible roles in situ have been elucidated to a certain extent, 7-9) though many issues remain to be clarified. Although TL − strains (e.g., C57BL/6 (B6) and C3H/He (C3H)) do not express TL in the thymus, a proportion of T lymphomas originating in these mice express TL as a serologically defined tumor antigen. 1,[10][11][12] In a previous study, we demonstrated that a certain fraction of N-butyl-N-nitrosourea (NBU)-induced lymphomas in C3H and B6 mice express TL, but the expression profiles are somewhat different between these two strains.12) TL is expressed by only a half of the C3H-derived lymphomas (8/16), but most B6-derived lymphomas are TL-positive (16/17). In another study, we derived Tg.Con.3-1 and Tg.Con.3-2 transgenic mice (C3H background) expressing T3 b -TL ubiquitously 13,14) and demonstrated that TL can serve as a transplantation antigen by grafting the skin of these mice onto syngeneic C3H. 15) We also showed that immune responses against grafted skins are weaker in (B6×C3H)F 1 than in C3H mice. Especially, when skins from Tg.Con.3-2 (a lower expresser of TL) were grafted on F 1 mice, none was rejected, in contrast to the case of C3H. These observations together suggest that immunity against TL is weaker in B6 than in C3H, and that anti-TL immunity may contribute to the resistance to lymphoma development in these mice.To further examine this possibility, in the present study, we administered NBU orally to C3H and B6, as well as T3 b -TL gene-transduced counterparts, Tg.Con.3-1 and B6.Tg.Con.3-1. The observed faster lymphoma development in the T3 b -TL gene-transduced mice, in which TL-reactive lymphocytes are most likely to be eliminated and/or anergized, provided support for anti-TL immunity playing a protective role against lymphoma growth in vivo. Furthermore, the onset o...